Source: Johns Hopkins Medical Institutions
04.25.2007
A Johns Hopkins team has stopped in its tracks a form of blood cancer in mice by engineering and inactivating an enzyme, telomerase, thereby shortening the ends of chromosomes, called telomeres.
External Link: http://www.eurekalert.org/pub_releases/2007-04/jhmi-scp04250...